43 results
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
8 Jul 24
Annual General and Special Meeting of the Shareholders to Be Held on Management Information Circular
5:16pm
directors and officers, where permitted, and for direct indemnity of directors and officers where corporate reimbursement is not permitted by law … or reimbursement of any costs, or payment of any cost advance, by the Company under any provision of the agreements, or under any other agreement
6-K
QNTM
Quantum BioPharma Ltd
21 Feb 24
Current report (foreign)
8:46pm
. The Corporation defended the arbitration and counterclaimed against Dr. Bokhari for reimbursement of expenses he directed the Corporation to pay
6-K
EX-10.1
QNTM
Quantum BioPharma Ltd
20 Feb 24
FSD Pharma Announces US ATM Offering
6:01am
for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
424B5
qvq14mqb2 3d
16 Feb 24
Prospectus supplement for primary offering
6:36pm
F-3
c34f5l
22 Dec 23
Shelf registration (foreign)
6:49pm
6-K
EX-99.2
2fm84s9vd01pasn1692h
14 Nov 22
Condensed consolidated interim financial statements
6:02am
6-K
EX-99.2
6gsf9x9zosma
12 Aug 22
Condensed consolidated interim financial statements
4:58pm
6-K
EX-99.1
wbyzho9rlkzy hk0
23 May 22
Annual General Meeting of the Shareholders
4:29pm
6-K
EX-99.2
wergdz c8zhjsu0ch4
13 May 22
Condensed consolidated interim financial statements
5:10pm
20-F
EX-4.15
u0oo5fk15q76n5pu
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-15.1
ljhb4ds5kgjj44jmirhl
31 Mar 22
Annual report (foreign)
8:09am
20-F
9fhsy
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-4.14
d0mqvw2dt4khgj
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-4.16
61wjqga
31 Mar 22
Annual report (foreign)
8:09am